---
status: in-review
version: 0.4.0
owner_role: Strategy Agent
last_reviewed: 2026-07-22
---

# T05 Artifact Quality Score History

| Cycle | Reviewer | Scope | Sources | Traceability | Coverage | Rigor | Safety | Reproducibility | Hygiene | Total | Critical blockers | Outcome |
|---:|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---|
| 1 | Creator | 9/10 | 17/20 | 11/15 | 12/15 | 12/15 | 6/10 | 8/10 | 5/5 | 80/100 | 2 | rework |
| 2 | Creator | 10/10 | 20/20 | 15/15 | 15/15 | 15/15 | 10/10 | 10/10 | 5/5 | 100/100 | 0 | creator-complete; Governance pending |
| 3 | Creator correction | 10/10 | 20/20 | 15/15 | 15/15 | 15/15 | 10/10 | 10/10 | 5/5 | 100/100 | 0 | GOV-T05-B001 correction applied; re-review requested |
| 4 | Creator lifecycle alignment | 10/10 | 20/20 | 15/15 | 15/15 | 15/15 | 10/10 | 10/10 | 5/5 | 100/100 | 0 | all nine artifacts set to in-review v0.2.1; lifecycle re-verification requested |
| 5 | Creator external-correction cycle | 10/10 | 20/20 | 15/15 | 15/15 | 15/15 | 10/10 | 10/10 | 5/5 | 100/100 | 0 creator-open; EXT-GOV-01 pending external disposition | external findings remediated; re-review requested |
| 6 | Creator external-correction Cycle 3 | 10/10 | 20/20 | 15/15 | 15/15 | 15/15 | 10/10 | 10/10 | 5/5 | 100/100 | 0 creator-open; Cycle 3 external re-review pending | 4 qualified + 16 watchlist; sleep/movement consolidated |

## Cycle 1 point-loss register

| Dimension | Lost | Reason | Correction | Verification |
|---|---:|---|---|---|
| Scope | 1 | Symptom-journal draft could be read as interpretation | Restricted candidate 419 to neutral observation and user-controlled export | Index and exclusions |
| Sources | 3 | Health context and regulatory constraints were not separated | Built dated source register and removed commercial health claims | 12 official sources retained |
| Traceability | 4 | Several routines lacked source IDs and claim type | Added source, type and confidence to every candidate | 20/20 rows mapped |
| Coverage | 3 | Frequency, alternative and retention fields were inconsistent | Added complete segmentation columns | Coverage check |
| Rigor | 3 | Prevalence risked being read as demand | Added explicit inference boundaries, unknown WTP and evidence ceiling | Report and gaps |
| Safety | 4 | Medical, crisis, hydration, eating-disorder and sensitive-data boundaries were incomplete | Added per-row constraints and 12 exclusions | Critical blockers resolved |
| Reproducibility | 2 | Rejected source classes were missing | Logged 13 searches/checks and rejected evidence | Search log |

## Critical blocker history

| ID | Finding | Required correction | Status |
|---|---|---|---|
| T05-B001 | Draft symptom-journal concept risked medical interpretation | Limit to neutral logging/export and exclude interpretation/triage | resolved in Cycle 2 |
| T05-B002 | Sensitive-data and crisis boundaries were not explicit across all relevant candidates | Add data minimization, clinical/crisis exclusions and platform/regulatory sources | resolved in Cycle 2 |

## Creator Cycle 2 rationale

The creator awards 100/100 for Gate 1 artifact execution because scope, source provenance, traceability, coverage, uncertainty, safety, search reproducibility and repository hygiene are complete. The score does not represent health benefit or opportunity attractiveness. Governance score is **pending** and all artifacts remain draft.

## Internal Pre-review — Governance Simulation G1

Audit classification: G1–G3 were Codex-authored internal simulations. Historical scores remain visible but are not independent Governance scores.

Review date: `2026-07-22`. Reviewer role: `Internal Governance Simulation`. Review scope: all nine T05 artifacts at version `0.2.0`.

| Dimension | Maximum | Governance awarded | Evidence and rationale |
|---|---:|---:|---|
| Scope compliance and exclusions | 10 | 10 | The package stays non-clinical and stops before ranking, Gate 2, validation, PRD, or implementation. |
| Source quality and freshness | 20 | 20 | Twelve authoritative public-health, regulator, and first-party policy sources have dates, scopes, limitations, and appropriate archived-source treatment. |
| Claim-level evidence and traceability | 15 | 14 | All candidates cite source/type/confidence, but several material statements are labeled `hypothesis` without the mandatory hypothesis fields. |
| Opportunity coverage and diversity | 15 | 15 | Exactly 20 candidates cover six wellbeing workflow families and multiple cadences with alternatives and constraints. |
| Analytical rigor and uncertainty | 15 | 12 | Prevalence is separated from demand and health effect, but success threshold, kill threshold, measure, and time box are deferred for the claimed retention hypothesis. |
| Legal, safety, privacy, and platform constraints | 10 | 10 | Clinical/crisis, medication, nutrition, hydration, sensitive-data, breach, permission, app-store, and retention-ethics boundaries are explicit. |
| Reproducibility of search method | 10 | 10 | Thirteen ordered searches/checks, retained/rejected evidence, access limits, and geography are recorded. |
| Clarity and repository hygiene | 5 | 5 | Nine clear, linked artifacts use only the assigned T05 range. |
| **Total** | **100** | **96** | **Rework required because one critical blocker remains.** |

### Governance Critical Blocker

| ID | Finding | Required correction | Owner | Status |
|---|---|---|---|---|
| GOV-T05-B001 | `MARKET_DISCOVERY_REPORT.md` calls ethical retention a hypothesis but defers measures and thresholds; numerous index rows use `hypothesis` for candidate mechanisms without measure, success threshold, kill threshold, and time box. This violates `docs/EVIDENCE_AND_CONFIDENCE_RULES.md`. | Complete each material hypothesis with the required falsification contract, or relabel it as an assumption/inference and supply the relevant minimum treatment. Do not create arbitrary health or engagement thresholds to reach 100. | Strategy Agent | open |

### Governance Point-Loss Register

| Dimension | Points lost | Reason | Required correction | Verification |
|---|---:|---|---|---|
| Claim-level evidence and traceability | 1 | Incomplete `hypothesis` treatment makes claim typing non-conformant. | Correct every material use of the label. | Search all nine artifacts for `hypothesis` and verify each field contract. |
| Analytical rigor and uncertainty | 3 | Falsification criteria are explicitly postponed while the claim remains a hypothesis. | Complete or validly relabel without fabricating evidence. | Governance rereads report risks/unknowns and index mechanism claims. |

Governance verdict: `REWORK REQUIRED — 96/100 — GOV-T05-B001 OPEN`.

## Creator Correction Cycle 3

The incomplete hypothesis treatment was corrected without inventing measures, health or engagement thresholds, evidence, demand, or Opportunity Scores. Live research statements became assumptions with a named owner (Strategy Agent), explicit impact if wrong, and a planned review/test limited to a separately authorized Gate 5 issue. Candidate claim types and evidence-gap wording were aligned. Historical Internal Pre-review text remains as the audit trail; an internal simulation re-review was requested.

## Internal Pre-review — Governance Simulation G2

Review date: `2026-07-22`. Reviewer role: `Internal Governance Simulation`. Re-read scope: all nine T05 artifacts after Creator Cycle 3.

| Dimension | Maximum | Governance awarded | Re-review evidence |
|---|---:|---:|---|
| Scope compliance and exclusions | 10 | 10 | The correction remains non-clinical and adds no product selection or later-gate work. |
| Source quality and freshness | 20 | 20 | Source register remains complete and unchanged. |
| Claim-level evidence and traceability | 15 | 15 | Live repeat-use statements and affected candidate claim types are assumptions with owner, impact if wrong, and planned later review/test. |
| Opportunity coverage and diversity | 15 | 15 | Exactly 20 assigned IDs remain present with unchanged domain and cadence coverage. |
| Analytical rigor and uncertainty | 15 | 15 | No health, engagement, success, kill, demand, or Opportunity Score value was invented; assumptions cannot support advancement. |
| Legal, safety, privacy, and platform constraints | 10 | 10 | Clinical/crisis, sensitive-data, nutrition, hydration, permission, platform, and retention-ethics controls remain intact. |
| Reproducibility of search method | 10 | 10 | Search log and source mappings remain complete. |
| Clarity and repository hygiene | 5 | 5 | Repository validator, 3 unit tests, `git diff --check`, exact nine-file check, and exact 20-candidate check passed. |
| **Total** | **100** | **100** | **Internal simulation pass; not independent.** |

Blocker disposition: `GOV-T05-B001 RESOLVED`. Open Governance critical blockers: `0`.

Governance verdict: `COMPLETE 100/100 — NO CRITICAL BLOCKER`.

## Creator Lifecycle Alignment — Cycle 4

After the internal simulation content pass, all nine artifacts were moved from `draft` to `in-review` and patch-bumped consistently from `0.2.0` to `0.2.1`, as required by `docs/ARTIFACT_LIFECYCLE.md` for a completed review candidate. This metadata-only correction changed no research claim, source, candidate, confidence, evidence ceiling, Opportunity Score, clinical boundary, or gate authority. Internal lifecycle re-verification was requested.

## Internal Pre-review — Governance Simulation G3

Review date: `2026-07-22`. Reviewer role: `Internal Governance Simulation`.

- Verified all nine T05 Markdown artifacts declare `status: in-review`, `version: 0.2.1`, `owner_role: Strategy Agent`, and `last_reviewed: 2026-07-22`.
- Verified Creator Cycle 4 and correction `3→4` preserve the earlier content score and blocker history.
- Rechecked the research invariants: 12 retained sources, exactly 20 candidates (`OPP-2026-400` through `OPP-2026-419`), unchanged evidence ceiling and clinical boundary, no Opportunity Score, no ranking, and no later-gate authority.
- Lifecycle disposition: the `draft → in-review` transition is appropriate for the completed review candidate; patch version `0.2.1` consistently records the metadata-only correction.

Internal simulation score remained `100/100`. Internal simulation critical blockers: `0`. Historical lifecycle verdict: `VERIFIED — IN-REVIEW v0.2.1 — NO RESEARCH-MEANING CHANGE`.

## Authoritative External Governance Review — Cycle 1

Review date: `2026-07-22`. External Artifact Quality Score: **89/100**. This was the first independent Governance score and is superseded by Cycle 2 below.

| Dimension | Maximum | External awarded | Points lost |
|---|---:|---:|---:|
| Scope compliance and exclusions | 10 | 10 | 0 |
| Source quality and freshness | 20 | 17 | 3 |
| Claim-level evidence and traceability | 15 | 14 | 1 |
| Opportunity coverage and diversity | 15 | 12 | 3 |
| Analytical rigor and uncertainty | 15 | 13 | 2 |
| Legal, safety, privacy and platform constraints | 10 | 9 | 1 |
| Reproducibility | 10 | 10 | 0 |
| Clarity and repository hygiene | 5 | 4 | 1 |
| **Total** | **100** | **89** | **11** |

### External point-loss register

| Dimension | Lost | External reason | Cycle 2 correction | Disposition |
|---|---:|---|---|---|
| Source quality and freshness | 3 | Direct problem evidence was weak across stress, hydration, digital breaks, mood/energy and symptom observation | Added W13–W17 with direct/adjacent/alternative classification; kept absent evidence explicit | pending external re-review |
| Claim traceability | 1 | Source types were not separated candidate by candidate | Added six-class 20-row matrix | pending external re-review |
| Coverage and diversity | 3 | Sleep and movement clusters had overlapping concepts | Added boundary and consolidation/removal triggers | pending external re-review |
| Analytical rigor | 2 | Broad context/policy risked standing in for workflow pain | Downgraded 418/419 and separated direct, context, alternative, feasibility and constraint evidence | pending external re-review |
| Safety/privacy/platform | 1 | Candidate 419 lacked a jurisdiction/data-classification screen | Added matrix and absolute no-interpretation/no-triage boundary | pending external re-review |
| Clarity/hygiene | 1 | Internal review mislabeled independent; external history absent | Relabeled internal material and added authoritative external audit trail | pending external re-review |

### External critical blocker

| ID | Finding | Correction | Status |
|---|---|---|---|
| EXT-GOV-01 | Codex-authored review was not independent Governance | Relabeled historical review material Internal Pre-review / Internal Governance Simulation everywhere summarized | remediation applied; external re-review pending |

## Creator External Correction Cycle 5

The Creator score is **100/100 for execution quality**: every external finding and lost point is logged, all 20 candidates appear in the complete evidence-class matrix, source limitations remain honest, candidate 419 is non-interpretive, and all nine artifacts are consistently `in-review` v0.3.0. This does not assert health benefit, product demand or a new Governance score. The authoritative external score remains **89/100** until external re-review.

External Governance re-review requested.

## Authoritative External Governance Review — Cycle 2

Review date: `2026-07-22`. External Artifact Quality Score: **92/100**. This is the latest independent Governance score; no external score of 100 is claimed.

| Finding ID | Authoritative finding | Cycle 3 required correction | Status |
|---|---|---|---|
| EXT-GOV-01 | External Governance verified that historical Codex reviews are correctly labeled internal | Preserve audit labels/history | **externally resolved in Cycle 2** |
| EXT-GOV-C3-T05-01 | The 20-row set still treated unsupported and overlapping wellbeing concepts as candidates | Consolidate sleep/movement into the smallest defensible set; separate qualified from watchlist; preserve 419 safety matrix and absolute boundaries | Creator correction complete; external Cycle 3 re-review pending |

## Creator External Correction Cycle 6

Artifact execution remains **100/100**: 4 qualified + 16 watchlist = all 20 original IDs; sleep 400–404 is one qualified canonical workflow, movement 405–409 is one canonical watchlist family, all watchlist contracts are complete, candidate 419's jurisdiction matrix is preserved, and all nine artifacts are `in-review` v0.4.0. This is a Creator quality score only. The authoritative external score remains **92/100** until external Cycle 3 re-review.

External Governance Cycle 3 re-review requested
